Aquilo Capital Management as of June 30, 2019
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 13 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| iShares NASDAQ Biotechnology Index (IBB) | 37.9 | $109M | 1.0M | 109.10 | |
| SPDR S&P Biotech (XBI) | 15.2 | $44M | 500k | 87.71 | |
| Uniqure Nv (QURE) | 9.9 | $29M | 365k | 78.15 | |
| Merus N V (MRUS) | 7.1 | $20M | 1.4M | 14.65 | |
| Arrowhead Pharmaceuticals (ARWR) | 5.1 | $15M | 558k | 26.50 | |
| Spero Therapeutics (SPRO) | 4.6 | $13M | 1.2M | 11.51 | |
| Fate Therapeutics (FATE) | 4.2 | $12M | 602k | 20.30 | |
| Synlogic | 3.3 | $9.5M | 1.0M | 9.10 | |
| Xenon Pharmaceuticals (XENE) | 3.3 | $9.4M | 952k | 9.86 | |
| Bicycle Therapeutics (BCYC) | 2.6 | $7.4M | 738k | 10.06 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 2.4 | $6.8M | 749k | 9.10 | |
| Pieris Pharmaceuticals (PIRS) | 2.4 | $6.8M | 1.5M | 4.70 | |
| Galapagos Nv- (GLPG) | 2.1 | $6.0M | 47k | 128.93 |
